Drug-resistant tuberculosis in sub-saharan Africa
- PMID: 21308497
- DOI: 10.1007/s11908-009-0074-7
Drug-resistant tuberculosis in sub-saharan Africa
Abstract
Drug-resistant tuberculosis (DRTB) is an emerging infectious disease threat to sub-Saharan Africa (SSA), particularly in the regions hit hardest by the HIV epidemic. Numerous challenges face clinicians and public health officials tasked with combating DRTB in SSA. These include difficulties providing effective diagnosis, treatment, and prevention of this illness. Furthermore, combating DRTB requires addressing various legal and ethical complexities. A sustained commitment to investigating as well as implementing new diagnostic, therapeutic, and preventative interventions is essential to defeating this threat.
Similar articles
-
Programmatic and ethical challenges in the implementation of treatment-as-prevention in the context of HIV and drug-resistant tuberculosis co-infection in sub-Saharan Africa.Glob Public Health. 2016 Mar;11(3):336-347. doi: 10.1080/17441692.2014.988164. Epub 2014 Dec 16. Glob Public Health. 2016. PMID: 25513964
-
Tuberculosis in prisons in sub-Saharan Africa--the need for improved health services, surveillance and control.Tuberculosis (Edinb). 2011 Mar;91(2):173-8. doi: 10.1016/j.tube.2010.12.002. Epub 2011 Jan 20. Tuberculosis (Edinb). 2011. PMID: 21251881 Review.
-
HIV epidemic and human rights among men who have sex with men in sub-Saharan Africa: Implications for HIV prevention, care, and surveillance.Glob Public Health. 2017 Apr;12(4):469-482. doi: 10.1080/17441692.2015.1094107. Epub 2015 Oct 30. Glob Public Health. 2017. PMID: 26514443
-
Scaling up pre-exposure prophylaxis in sub-Saharan Africa.Curr Opin Infect Dis. 2019 Feb;32(1):24-30. doi: 10.1097/QCO.0000000000000511. Curr Opin Infect Dis. 2019. PMID: 30461452 Review.
-
Tuberculosis in sub-Saharan Africa: a regional assessment of the impact of the human immunodeficiency virus and National Tuberculosis Control Program quality.Tuber Lung Dis. 1996 Jun;77(3):220-5. doi: 10.1016/s0962-8479(96)90004-0. Tuber Lung Dis. 1996. PMID: 8758104
Cited by
-
Emerging threat of drug-resistant tuberculosis and trends in the era of COVID-19: A descriptive study from northwestern Nigeria.J Clin Tuberc Other Mycobact Dis. 2022 May 17;28:100319. doi: 10.1016/j.jctube.2022.100319. eCollection 2022 Aug. J Clin Tuberc Other Mycobact Dis. 2022. PMID: 35599722 Free PMC article.
-
Dipterinyl calcium pentahydrate inhibits intracellular mycobacterial growth in human monocytes via the C-C chemokine MIP-1β and nitric oxide.Infect Immun. 2013 Jun;81(6):1974-83. doi: 10.1128/IAI.01393-12. Epub 2013 Mar 18. Infect Immun. 2013. PMID: 23509148 Free PMC article.
-
Tuberculosis incidence and treatment completion among Ugandan prison inmates.Int J Tuberc Lung Dis. 2014 Jul;18(7):781-6. doi: 10.5588/ijtld.13.0934. Int J Tuberc Lung Dis. 2014. PMID: 24902552 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Research Materials